U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination
    • Showing Current items.

    MIR128-1 microRNA 128-1 [ Homo sapiens (human) ]

    Gene ID: 406915, updated on 2-Nov-2024

    GeneRIFs: Gene References Into Functions

    GeneRIFPubMed TitleDate
    Role of miR-128-3p and miR-195-5p as biomarkers of coronary artery disease in Indians: a pilot study.

    Role of miR-128-3p and miR-195-5p as biomarkers of coronary artery disease in Indians: a pilot study.
    Choudhury RR, Gupta H, Bhushan S, Singh A, Roy A, Saini N., Free PMC Article

    06/11/2024
    miR-128-3p alleviates airway inflammation in asthma by targeting SIX1 to regulate mitochondrial fission and fusion.

    miR-128-3p alleviates airway inflammation in asthma by targeting SIX1 to regulate mitochondrial fission and fusion.
    Liu X, Cui H, Bai Q, Piao H, Song Y, Yan G.

    03/29/2024
    Competitive binding of circCCDC6 to microRNA-128-3p activates TXNIP/NLRP3 pathway and promotes cerebral ischemia-reperfusion defects.

    Competitive binding of circCCDC6 to microRNA-128-3p activates TXNIP/NLRP3 pathway and promotes cerebral ischemia-reperfusion defects.
    Wang C, Dong M, Zhang X, Wang X, Zhao Y, Cao Y.

    12/27/2023
    miRNA-128 and miRNA-223 regulate cholesterol-mediated drug resistance in breast cancer.

    miRNA-128 and miRNA-223 regulate cholesterol-mediated drug resistance in breast cancer.
    Palma GBH, Kaur M.

    11/7/2023
    LncRNA FOXD3-AS1/miR-128-3p axis-mediated IGF2BP3 in glioma stimulates cancer angiogenesis and progression.

    LncRNA FOXD3-AS1/miR-128-3p axis-mediated IGF2BP3 in glioma stimulates cancer angiogenesis and progression.
    Zhao H, Wang Y, Liang C, Xie M.

    08/19/2023
    The Role of miR-128 in Neurodegenerative Diseases.

    The Role of miR-128 in Neurodegenerative Diseases.
    Lanza M, Cuzzocrea S, Oddo S, Esposito E, Casili G., Free PMC Article

    08/10/2023
    MiR-128-1-5p inhibits cell proliferation and induces cell apoptosis via targeting PRKCQ in colorectal cancer.

    MiR-128-1-5p inhibits cell proliferation and induces cell apoptosis via targeting PRKCQ in colorectal cancer.
    Jia Q, Liao X, Xu B, Li Y, Liang L., Free PMC Article

    06/29/2023
    ADAMTS9-AS1 Long Non-coding RNA Sponges miR-128 and miR-150 to Regulate Ras/MAPK Signaling Pathway in Glioma.

    ADAMTS9-AS1 Long Non‑coding RNA Sponges miR‑128 and miR-150 to Regulate Ras/MAPK Signaling Pathway in Glioma.
    Javanmard AR, Jahanbakhshi A, Nemati H, Mowla SJ, Soltani BM.

    06/26/2023
    MiR-128-3p as blood based liquid biopsy biomarker in childhood acute lymphoblastic leukemia.

    MiR-128-3p as blood based liquid biopsy biomarker in childhood acute lymphoblastic leukemia.
    Rzepiel A, Horváth A, Kutszegi N, Gézsi A, Sági JC, Almási L, Egyed B, Lőrincz P, Visnovitz T, Kovács GT, Szalai C, Semsei ÁF, Erdélyi DJ.

    03/16/2023
    The Interrelationship Between FYN and miR-128/193a-5p/494 in Imatinib Resistance in Prostate Cancer.

    The Interrelationship Between FYN and miR-128/193a-5p/494 in Imatinib Resistance in Prostate Cancer.
    Ergün S, Akgün O, Hekim NT, Aslan S, Ari F, Güneş S, Abur Ü.

    03/9/2023
    Expression of miR-128-3p, miR-193a-3p and miR-193a-5p in endometrial cancer tissues and their relationship with clinicopathological parameters.

    Expression of miR-128-3p, miR-193a-3p and miR-193a-5p in endometrial cancer tissues and their relationship with clinicopathological parameters.
    Wang X, Dai L, Liu J, Ge J.

    02/27/2023
    GLIDR promotes the aggressiveness progression of prostate cancer cells by sponging miR-128-3p.

    GLIDR promotes the aggressiveness progression of prostate cancer cells by sponging miR-128-3p.
    Li S, Wang Y, Cao Q, Li H, Zhao Z, Wei B, Yuan H, Chen Z, Yang S.

    02/23/2023
    Cinnamtannin B-1 Inhibits the Progression of Osteosarcoma by Regulating the miR-1281/PPIF Axis.

    Cinnamtannin B-1 Inhibits the Progression of Osteosarcoma by Regulating the miR-1281/PPIF Axis.
    Jia J, Xia J, Liu W, Tao F, Xiao J.

    01/14/2023
    miR-128-3p inhibits the inflammation by targeting MAPK6 in penicillin-induced astrocytes.

    miR-128-3p inhibits the inflammation by targeting MAPK6 in penicillin-induced astrocytes.
    Pang Y, Luo D, Wang S., Free PMC Article

    11/5/2022
    Early marker of ocular neurodegeneration in children and adolescents with type 1 diabetes: the contributing role of polymorphisms in mir146a and mir128a genes.

    Early marker of ocular neurodegeneration in children and adolescents with type 1 diabetes: the contributing role of polymorphisms in mir146a and mir128a genes.
    Piona C, Costantini S, Zusi C, Cozzini T, Pedrotti E, Marigliano M, Fornari E, Maguolo A, Morandi A, Maffeis C., Free PMC Article

    10/29/2022
    LncRNA NEAT1 induces autophagy through the miR-128-3p/ADAM28 axis to suppress apoptosis of nonsmall-cell lung cancer.

    LncRNA NEAT1 induces autophagy through the miR-128-3p/ADAM28 axis to suppress apoptosis of nonsmall-cell lung cancer.
    Xie Y, Zheng ZW, He HT, Chang ZB.

    10/15/2022
    MicroRNA-128-3p suppresses interleukin-1beta-stimulated cartilage degradation and chondrocyte apoptosis via targeting zinc finger E-box binding homeobox 1 in osteoarthritis.

    MicroRNA-128-3p suppresses interleukin-1β-stimulated cartilage degradation and chondrocyte apoptosis via targeting zinc finger E-box binding homeobox 1 in osteoarthritis.
    Sun Y, Bao X, Chen H, Zhou L., Free PMC Article

    02/26/2022
    microRNA-128-3p inhibits CD4+ regulatory T cells enrichment by targeting interleukin 16 in gastric cancer.

    microRNA-128-3p inhibits CD4+ regulatory T cells enrichment by targeting interleukin 16 in gastric cancer.
    Fang W, Shi C, Wang Y, Song J, Zhang L., Free PMC Article

    02/26/2022
    RUNX1 (RUNX family transcription factor 1), a target of microRNA miR-128-3p, promotes temozolomide resistance in glioblastoma multiform by upregulating multidrug resistance-associated protein 1 (MRP1).

    RUNX1 (RUNX family transcription factor 1), a target of microRNA miR-128-3p, promotes temozolomide resistance in glioblastoma multiform by upregulating multidrug resistance-associated protein 1 (MRP1).
    Xu J, Song J, Xiao M, Wang C, Zhang Q, Yuan X, Tian S., Free PMC Article

    02/19/2022
    HCP5 contributes to cisplatin resistance in gastric cancer through miR-128/HMGA2 axis.

    HCP5 contributes to cisplatin resistance in gastric cancer through miR-128/HMGA2 axis.
    Liang L, Kang H, Jia J., Free PMC Article

    02/12/2022
    LncRNA NEAT1 Enhances Glioma Progression via Regulating the miR-128-3p/ITGA5 Axis.

    LncRNA NEAT1 Enhances Glioma Progression via Regulating the miR-128-3p/ITGA5 Axis.
    Chen J, Wang H, Wang J, Niu W, Deng C, Zhou M., Free PMC Article

    02/5/2022
    MiR-128-3p suppresses tumor proliferation and metastasis via targeting CDC6 in hepatocellular carcinoma cells.

    MiR-128-3p suppresses tumor proliferation and metastasis via targeting CDC6 in hepatocellular carcinoma cells.
    Shi Y, Yan F, Wang F, Pan L.

    01/22/2022
    HIV-infection and cocaine use regulate semen extracellular vesicles proteome and miRNAome in a manner that mediates strategic monocyte haptotaxis governed by miR-128 network.

    HIV-infection and cocaine use regulate semen extracellular vesicles proteome and miRNAome in a manner that mediates strategic monocyte haptotaxis governed by miR-128 network.
    Kaddour H, Kopcho S, Lyu Y, Shouman N, Paromov V, Pratap S, Dash C, Kim EY, Martinson J, McKay H, Epeldegui M, Margolick JB, Stapleton JT, Okeoma CM., Free PMC Article

    01/8/2022
    lncRNA SNHG22 sponges miR1283p to promote the progression of colorectal cancer by upregulating E2F3.

    lncRNA SNHG22 sponges miR‑128‑3p to promote the progression of colorectal cancer by upregulating E2F3.
    Yao J, Wang C, Dong X, Zhang Y, Li Y, Zhou H, Zhang L., Free PMC Article

    01/8/2022
    miR-130b and miR-128a are essential lineage-specific codrivers of t(4;11) MLL-AF4 acute leukemia.

    miR-130b and miR-128a are essential lineage-specific codrivers of t(4;11) MLL-AF4 acute leukemia.
    Malouf C, Antunes ETB, O'Dwyer M, Jakobczyk H, Sahm F, Landua SL, Anderson RA, Soufi A, Halsey C, Ottersbach K.

    12/25/2021
    firstprevious page of 5 nextlast